BD Phoenix PMIC/ID-107: The Phoenix PMIC/ID panel is used for the… — Class II medical device recall Z-0232-2023

Ongoing recall by Becton Dickinson & Co., reported 2022-11-23, distributed nationwide. Misformulated minocycline-can cause erroneously increased Minimal Inhibitory Concentration (MIC) values when p

Recall number	`Z-0232-2023`
Product type	Medical device
Classification	Class II
Status	Ongoing
Voluntary or mandated	Voluntary
Recalling firm	Becton Dickinson & Co., Sparks, MD, United States
Recall initiated	2022-10-13
Classified	2022-11-14
Reported by FDA	2022-11-23
Distributed	Nationwide (US)
Quantity	13,900 units
UPC / GTIN / UDI-DI	`30382904486076`
Lot numbers	`1355046`
Model numbers	`448607`
Expiration dates	`2023-01-31`

Product

BD Phoenix PMIC/ID-107: The Phoenix PMIC/ID panel is used for the rapid identification and susceptibility of most aerobic and facultative anaerobic gram-positive bacteria of human origin with selected antimicrobial agents when used with the BD Phoenix Automated Microbiology System. Catalog (Ref) Number: 448607

Reason for recall

Misformulated minocycline-can cause erroneously increased Minimal Inhibitory Concentration (MIC) values when performing antibiotic susceptibility testing (AST) against minocycline and result in the reporting of false resistance for clinical samples if the initial Quality Control (QC) testing of the panel batch passes, delaying treatment of the patient with the most appropriate antibiotic

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0232-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.